By Jared S. Hopkins 

Pfizer Inc. said Tuesday it could have a coronavirus vaccine ready for use on an emergency basis in the fall if it proves to work safely in testing.

Testing of the vaccine, which has already started in Germany, could start in the U.S. as early as next week if health regulators sign off, Pfizer Chief Executive Albert Bourla said in an interview. Results from the study could come as early as next month, Mr. Bourla said.

Pfizer would need to do more testing to make sure the vaccine works safely. If all testing proves successful, Pfizer could start distributing the vaccine on an emergency basis in the fall and receive approval for widespread distribution by year's end, Mr. Bourla said.

"This is a crisis right now, and a solution is desperately needed by all, " Mr. Bourla said.

Write to Jared S. Hopkins at jared.hopkins@wsj.com

 

(END) Dow Jones Newswires

April 28, 2020 13:29 ET (17:29 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Pfizer Charts.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Pfizer Charts.